First-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Cancer With Regorafenib Plus Toripalimab
Conditions: Gastric Cancer; Gastro-oesophageal Junction Cancer; Immunotherapy; Regorafenib; Toripalimab Intervention: Drug: Regorafenib Plus Toripalimab Sponsor: Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Immunotherapy | Research